Therefore, we designed the in vivo experiments to investigate the effects of mild subclinical zinc deficiency on cognitive decline in the APP/PS1 mouse model of Alzheimer's disease and addressed whether any effects could be reversed by normalizing the levels of zinc. Here, APP is linked to Zinc deficiency.